• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEICA BIOSYSTEMS MELBOURNE PTY. LTD. PELORIS RAPID TISSUE PROCESSOR; AUTOMATED TISSUE PROCESSOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEICA BIOSYSTEMS MELBOURNE PTY. LTD. PELORIS RAPID TISSUE PROCESSOR; AUTOMATED TISSUE PROCESSOR Back to Search Results
Model Number PELORIS
Device Problem Device Operates Differently Than Expected (2913)
Patient Problem No Code Available (3191)
Event Date 08/07/2015
Event Type  Injury  
Event Description
Leica biosystems was advised that "tissue dried out on a run but wasn't discovered until 2 days after, the instrument has operated correctly since".On (b)(6) 2015, leica biosystems received information that re-biopsy of one (1) patient was necessary.The age and gender of the affected patient was provided.Investigation of this complaint by leica biosystems is in progress.
 
Manufacturer Narrative
The initial 30-day fda 3500a report cited (b)(6) 2015 as the date of event (mm/dd/yyyy).Investigation of this complaint determined the actual date of event (mm/dd/yyyy) is (b)(6) 2015.Based on the information provided, it was determined that the sub-optimal tissue processing reported is derived from the "factory 8hr xylene standard" protocol started in retort a at 16:23pm on (b)(6) 2015, which completed at 06:58am on (b)(6) 2015; and the "factory 12hr xylene standard" protocol started in retort b at 17:13pm on (b)(6) 2015, which completed at 10:58am on (b)(6) 2015.No use error(s) was identified in the instrument log in relation to the interaction between the user and the instrument either prior to, or during execution of the "factory 8hr xylene standard" protocol started in retort a at 16:23pm on (b)(6) 2015 and the "factory 12hr xylene standard" protocol started in retort b at 17:13pm on (b)(6) 2015, from which sub-optimal tissue processing was reported.The root cause of the sub-optimal tissue processing reported could not be determined from the information available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PELORIS RAPID TISSUE PROCESSOR
Type of Device
AUTOMATED TISSUE PROCESSOR
Manufacturer (Section D)
LEICA BIOSYSTEMS MELBOURNE PTY. LTD.
495 blackburn road
mount waverley, victoria 3149
AS  3149
Manufacturer (Section G)
LEICA BIOSYSTEMS MELBOURNE PTY. LTD.
495 blackburn road
mount waverley, victoria 3149
AS   3149
Manufacturer Contact
adrienne hardisty
495 blackburn road
mount waverley, victoria 3149
AS   3149
3 9211753
MDR Report Key5006509
MDR Text Key23089735
Report Number8020030-2015-00071
Device Sequence Number1
Product Code IEO
Combination Product (y/n)N
Reporter Country CodeUK
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other Health Care Professional
Report Date 08/10/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/17/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Model NumberPELORIS
Device Catalogue Number26.0001
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/10/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/05/2007
Is the Device Single Use? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age29 YR
-
-